A brain surgery study for drug-resistant epilepsy
Part of Brain & nervous system clinical trials.
This study tests a procedure that uses tiny electrodes to find and treat the area of the brain causing seizures in people with a specific type of epilepsy that does not get better with medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 14 and 65 years old
- Your seizures have not been controlled by at least two different medications
- You have at least two disabling seizures per month, with no more than 30 days between them
- An MRI shows shrinkage (atrophy) in one part of your hippocampus and a bright spot on T2 imaging on the same side
- Your brain wave tests (EEG) and brain scan (PET) show that your seizures start from one area on the same side of the brain
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of brain stimulation called temporal interference to help people with epilepsy that hasn't responded well to medications. Researchers want to see if this approach can reduce seizures and improve thinking or memory problems.
This trial tests a new type of brain scanner (MEG) to help locate the exact area in the brain causing seizures in people with drug-resistant epilepsy. The goal is to improve planning for surgery to remove that area.
This study tests a new “hybrid” type of electrodes placed inside the brain to better map where seizures start in people with difficult (drug-resistant) focal epilepsy. It may help doctors plan safer and more effective surgery, though it involves an invasive brain monitoring procedure.
This study tests how well a specific brain-recording device works during a procedure used to map seizure origins in people with drug-resistant, disabling focal epilepsy. It may help doctors plan treatment by improving how well they can localize the seizure focus before possible surgery.
This trial tests a type of brain stimulation therapy (TIS) for people with temporal lobe epilepsy that hasn't responded well to seizure medications. The goal is to help reduce how often seizures happen.
This trial tests a new type of stimulation placed under the skin to help control seizures in people with epilepsy. It is for patients whose seizures are not controlled with medication and who cannot have surgery.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.